Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析

◆英語タイトル:Nippon Chemiphar Co Ltd (4539) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14901
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. It offers diagnostic products, such as IgE NC, a diagnostic kit that provides results and reveals total IgE levels; and DP3000, a device for allergen-specific IgE measurements. Nippon Chemiphar offers products in the fields of hyperuricemia and algia. It offers solutions for internal medicine, orthopedics and urology. It distributes its generic pharmaceuticals through wholesalers to hospitals and pharmacies. The company operates in Yokohama, Kanetsu, Sapporo, Tokyo, Nagoya, Osaka, Hiroshima and Fukuoka. Nippon Chemiphar is headquartered in Tokyo, Japan.

Nippon Chemiphar Co Ltd Key Recent Developments

Nov 01,2018: Chemiphar announced Second Quarter Business Summary FY2018. (pdf, 340KB)

This comprehensive SWOT profile of Nippon Chemiphar Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nippon Chemiphar Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Nippon Chemiphar Co Ltd – Key Information
Nippon Chemiphar Co Ltd – Overview
Nippon Chemiphar Co Ltd – Key Employees
Nippon Chemiphar Co Ltd – Key Employee Biographies
Nippon Chemiphar Co Ltd – Key Operational Heads
Nippon Chemiphar Co Ltd – Major Products and Services
Nippon Chemiphar Co Ltd – History
Nippon Chemiphar Co Ltd – Company Statement
Nippon Chemiphar Co Ltd – Locations And Subsidiaries
Nippon Chemiphar Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Nippon Chemiphar Co Ltd – Business Description
Nippon Chemiphar Co Ltd – Corporate Strategy
Nippon Chemiphar Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Nippon Chemiphar Co Ltd – Strengths
Nippon Chemiphar Co Ltd – Weaknesses
Nippon Chemiphar Co Ltd – Opportunities
Nippon Chemiphar Co Ltd – Threats
Nippon Chemiphar Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Nippon Chemiphar Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Nippon Chemiphar Co Ltd, Key Information
Nippon Chemiphar Co Ltd, Key Ratios
Nippon Chemiphar Co Ltd, Share Data
Nippon Chemiphar Co Ltd, Major Products and Services
Nippon Chemiphar Co Ltd, History
Nippon Chemiphar Co Ltd, Key Employees
Nippon Chemiphar Co Ltd, Key Employee Biographies
Nippon Chemiphar Co Ltd, Key Operational Heads
Nippon Chemiphar Co Ltd, Other Locations
Nippon Chemiphar Co Ltd, Subsidiaries
Nippon Chemiphar Co Ltd, Key Manufacturing facilities
Nippon Chemiphar Co Ltd, Key Competitors
Nippon Chemiphar Co Ltd, SWOT Analysis
Nippon Chemiphar Co Ltd, Ratios based on current share price
Nippon Chemiphar Co Ltd, Annual Ratios
Nippon Chemiphar Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Nippon Chemiphar Co Ltd, Performance Chart
Nippon Chemiphar Co Ltd, Ratio Charts

★海外企業調査レポート[Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gulf Power Co:企業の発電所・SWOT分析2018
    Gulf Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Ypsomed Holding AG (YPSN):企業の財務・戦略的SWOT分析
    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Boston Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Advanced Technology Company (ATC):企業の財務・戦略的SWOT分析
    Advanced Technology Company (ATC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Inventiva (IVA)-製薬・医療分野:企業M&A・提携分析
    Summary Inventiva is a drug discovery company that endeavors to develop breakthrough therapies for cancer, fibrosis and rare diseases. The company’s product pipeline includes IVA336 for mucopolysaccharidosis type VI (MPS VI) and IVA337 for systemic sclerosis. Inventiva develops a novel internal canc …
  • Saudi Electricity Co (5110):企業の財務・戦略的SWOT分析
    Saudi Electricity Co (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Horizon Oil Ltd (HZN):企業の財務・戦略的SWOT分析
    Summary Horizon Oil Ltd (Horizon) is an oil and gas exploration and production company that acquires, explores, develops and produces oil and petroleum properties. The company holds interests in Maari and Manaia fields located in the Taranaki Basin approximately 80 kilometre offshore the north islan …
  • APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報
    Summary APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. A …
  • Lundin Mining Corporation:企業のM&A・事業提携・投資動向
    Lundin Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lundin Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • OSE Immunotherapeutics (OSE):製薬・医療:M&Aディール及び事業提携情報
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • The National Gas Company of Trinidad and Tobago Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary The National Gas Company of Trinidad and Tobago Ltd (NGC) is a state-owned natural gas company that purchases, compresses, transmits, distributes and sells natural gas to industrial and commercial customers. The company also has investments in the downstream and upstream segments of the natu …
  • Daiho Corporation:企業の戦略・SWOT・財務情報
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Starpharma Holdings Ltd (SPL):製薬・医療:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Ube Industries Ltd (4208):企業の財務・戦略的SWOT分析
    Ube Industries Ltd (4208) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Malayan Insurance Co. Inc.:企業の戦略・SWOT・財務情報
    Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary Malayan Insurance Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Arista Investors Corp:企業の戦略・SWOT・財務情報
    Arista Investors Corp - Strategy, SWOT and Corporate Finance Report Summary Arista Investors Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Eternygen GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research o …
  • BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outc …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Progenity Inc:医療機器:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆